Genocea Biosciences Inc

NASDAQ:GNCA  
2.36
+0.04 (+1.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Genocea Biosciences Inc Stock, NASDAQ:GNCA

Cambridge Discovery Park, 100 Acorn Park Drive, Cambridge, Massachusetts 02140
United States of America
Phone: +1.617.876.8191
Number of Employees: 72

Description

Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. The firm uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.